Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...